Artemis Medicare Services Ltd

Artemis Medicare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Artemis Medicare Services Ltd

₹ 216 -0.06%
22 Jul - close price
artemishospitals.com BSE: 542919 NSE: ARTEMISMED
About

Artemis Medicare Services Ltd (AMSL) was incorporated on 2004, by the promoters of the Apollo Tyres Group, is engaged in healthcare business. AMSL operates a 541-bedded multi-specialty tertiary care hospital in Gurgaon. The specialty areas for AMSL include Orthopaedics, Oncology, Cardiovascular, Neurosciences and Bariatric & Minimally Invasive Surgery. ASML has been awarded with the NABH and JCI accreditation. AMSL has also diversified its presence through Artemis Daffodil , Artemis Lite, Artemis Cardiac Care and Artemis Solace models. [1][2]

Key Points

Geographical Revenue Break-up 9MFY24:[1]
Domestic : ~76%
Outside India : ~24%

Website BSE NSE
  • Market Cap ₹ 2,966 Cr.
  • Current Price ₹ 216
  • High / Low ₹ 249 / 117
  • Stock P/E 60.6
  • Book Value ₹ 33.0
  • Dividend Yield 0.21 %
  • ROCE 13.6 %
  • ROE 11.5 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Stock is trading at 6.55 times its book value
  • Promoter holding has decreased over last quarter: -0.52%
  • Company has a low return on equity of 10.3% over last 3 years.
  • Promoters have pledged 44.5% of their holding.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
129 122 139 144 149 167 187 187 195 210 225 219 225
109 109 119 126 132 148 164 162 170 182 191 186 187
Operating Profit 20 13 20 18 17 19 23 26 26 28 34 33 38
OPM % 16% 11% 14% 12% 11% 11% 13% 14% 13% 13% 15% 15% 17%
5 1 1 1 1 2 1 1 2 1 2 2 2
Interest 3 2 3 3 4 4 5 5 5 7 8 8 9
Depreciation 5 5 5 6 6 7 7 8 9 9 10 10 11
Profit before tax 17 6 13 10 8 11 13 13 14 13 19 16 20
Tax % 26% 41% 36% 36% -61% 22% 31% 23% 24% 26% 28% 29% 29%
13 4 8 6 13 8 9 10 11 10 14 12 14
EPS in Rs 0.96 0.29 0.62 0.49 1.00 0.63 0.68 0.78 0.79 0.72 1.00 0.85 1.04
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
547 565 408 555 737 879
481 503 373 487 643 746
Operating Profit 66 62 35 68 94 133
OPM % 12% 11% 9% 12% 13% 15%
2 4 7 3 7 7
Interest 11 13 13 12 20 31
Depreciation 20 23 22 22 31 40
Profit before tax 37 31 8 37 51 68
Tax % 45% 36% 18% 16% 25% 28%
20 19 6 31 38 49
EPS in Rs 0.97 1.49 0.49 2.40 2.88 3.62
Dividend Payout % 0% 0% 0% 0% 16% 12%
Compounded Sales Growth
10 Years: %
5 Years: 10%
3 Years: 29%
TTM: 19%
Compounded Profit Growth
10 Years: %
5 Years: 18%
3 Years: 103%
TTM: 32%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 82%
1 Year: 68%
Return on Equity
10 Years: %
5 Years: 8%
3 Years: 10%
Last Year: 12%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 13 13 13 13 13 14
Reserves 280 300 307 346 390 435
114 113 147 201 286 320
147 160 133 149 216 203
Total Liabilities 554 586 600 710 905 972
381 393 383 489 605 719
CWIP 49 56 81 64 95 33
Investments 0 0 0 0 0 0
124 137 136 157 205 219
Total Assets 554 586 600 710 905 972

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
40 56 27 60 127 109
-50 -26 -37 -107 -158 -87
14 -27 18 44 38 -30
Net Cash Flow 5 2 8 -3 7 -8

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 52 49 49 48 46 39
Inventory Days
Days Payable
Cash Conversion Cycle 52 49 49 48 46 39
Working Capital Days -26 -28 -16 -9 -26 -13
ROCE % 10% 4% 10% 11% 14%

Shareholding Pattern

Numbers in percentages

1 Recently
Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
69.82% 69.82% 69.82% 69.59% 69.27% 68.91% 68.91% 68.03% 68.03% 68.03% 68.03% 67.51%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.07% 0.09% 0.11% 0.10% 0.16%
1.22% 1.22% 1.10% 0.91% 0.90% 1.15% 1.37% 1.41% 1.51% 1.96% 2.61% 3.45%
7.37% 7.37% 7.37% 7.34% 7.31% 7.27% 7.27% 7.18% 7.18% 7.18% 7.18% 7.12%
21.59% 21.59% 21.71% 22.17% 22.53% 22.65% 22.43% 23.30% 23.18% 22.72% 22.08% 21.76%
No. of Shareholders 10,76512,82712,09815,17714,63717,99518,10019,08220,52922,37519,99319,795

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls

  • May 2024
    Transcript
    Notes
    PPT
  • Feb 2024
    Transcript
    Notes
    PPT
  • Feb 2024
    Transcript
    Notes
    PPT
  • Nov 2023
    Transcript
    Notes
    PPT
  • Aug 2023
    Transcript
    Notes
    PPT
  • May 2023
    Transcript
    Notes
    PPT
  • Feb 2023
    Transcript
    Notes
    PPT
  • Nov 2022
    Transcript
    Notes
    PPT